You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

List of Excipients in API promethazine hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing promethazine hydrochloride

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
ANI Pharmaceuticals Inc PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE promethazine hydrochloride and dextromethorphan hydrobromide 62559-758 ALCOHOL
ANI Pharmaceuticals Inc PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE promethazine hydrochloride and dextromethorphan hydrobromide 62559-758 ANHYDROUS CITRIC ACID
ANI Pharmaceuticals Inc PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE promethazine hydrochloride and dextromethorphan hydrobromide 62559-758 ASCORBIC ACID
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for promethazine hydrochloride

Excipient focus: ACETIC ACID

Excipient focus: ALCOHOL

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: AQUA

Excipient focus: ASCORBIC ACID

Excipient focus: ASCORBYL PALMITATE

Excipient focus: CALCIUM CHLORIDE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COCOA BUTTER

Excipient focus: CORN SYRUP

Excipient focus: D&C RED NO. 27

Excipient focus: D&C RED NO. 30

Excipient focus: D&C RED NO. 33

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE SODIUM

Excipient focus: FAT, HARD

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: HARD FAT

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LEVOMENTHOL

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MENTHOL

Excipient focus: METHYLCELLULOSE

Excipient focus: METHYLPARABEN

Excipient focus: MINT

Excipient focus: PEACH

Excipient focus: PHENOL

Excipient focus: POLYSORBATE 80

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SACCHARIN

Excipient focus: SACCHARIN SODIUM

Excipient focus: SACCHARIN SODIUM DIHYDRATE

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM ACETATE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM METABISULFITE

Excipient focus: SODIUM PROPIONATE

Excipient focus: SODIUM PROPIONATE ANHYDROUS

Excipient focus: SODIUM PROPIONATE HYDRATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITOL

Excipient focus: STEARIC ACID

Excipient focus: SUCRALOSE

Excipient focus: SUCROSE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Excipient focus: WHITE WAX

Excipient focus: YELLOW 10

Excipient focus: YELLOW 6

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links